Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
暂无分享，去创建一个
Shaji K. Kumar | F. Hernandez-Ilizaliturri | J. Pagel | D. Mahadevan | A. Yee | G. Gregory | C. Escobar | W. Rybka | R. Bannerji | N. Wagner-Johnston | M. Farooqui | Julie E. Chang | H. Quach | P. Walker | A. Klein | A. Mohrbacher | Ding Wang | P. Marinello | D. Bhutani | Mo Huang | Mo Huang | Mouzhen Huang